Navigation Links
National Pharmaceutical Council Welcomes Shire as Its Newest Member
Date:8/3/2011

WASHINGTON, Aug. 3, 2011 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today welcomed global specialty biopharmaceutical company Shire plc as a new member. Dr. Jeffrey M. Jonas, senior vice president, specialty pharma R&D, will serve as Shire's representative on the NPC board of directors.

"The last few years have brought change to the health care environment that has left many important questions unresolved.  For the pharmaceutical industry, how comparative effectiveness research will be conducted and used is critical. We welcome Shire and look forward to their contribution to our shared mission of helping to answer these questions and chart the future," said NPC President Dan Leonard.

Shire, with facilities in Pennsylvania and Massachusetts, is focused on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. 

"Shire is very supportive of NPC's focus on evidence-based medicine and on policy research related to comparative effectiveness research, pharmaceutical innovation and the value of medicines," said Dr. Jonas. "We're pleased to be a part of this organization and look forward to working with NPC on issues affecting the pharmaceutical industry."

In becoming an NPC member, Shire joins with other leading research-based pharmaceutical companies, including Abbott Laboratories, Astra Zeneca LP, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals Inc., Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., Eisai inc., GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Otsuka America Pharmaceutical, Inc., Pfizer Inc, sanofi-aventis, and Teva Neuroscience.

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org.


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FedEx Donates $5 Million and MD-10-30 Aircraft to ORBIS International
2. FDA, International Counterparts Report Progress on Drug Inspection Collaboration
3. Chindex International, Inc. to Report Financial Results for the Second Quarter and First Half of 2011
4. Medela Announces 2011 Breastfeeding Hall of Excellence Inductees to Nationally Recognize Exceptional Breastfeeding Advocates
5. Elsevier Supports International Medical Corps Through Act to Save a Life Campaign
6. CVS Caremark Showcases Workplace and Marketplace Diversity at 2011 National Urban League Conference
7. H. D. Smith Reorganizes National Leadership for Continued Focus on Regional Customer Needs; Support Company Growth
8. Vystar® Corporation Spotlights Advantages of Vytex® NRL at the 13th Annual International Latex Conference
9. Pharmaceutics International, Inc. (Pii) Expands Drug Formulation and Manufacturing Capabilities with Hot Melt Extrusion Technology
10. Epitomics Releases New Antibodies Developed With the National Cancer Institutes Center for Cancer Research
11. Aeras and China National Biotech Group Sign Memorandum of Understanding for TB Vaccine R&D Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... 2, 2017 Halo Labs announces the European launch of ... the HORIZON at MIBio 2017 in Cambridge, U.K ... particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity while ... technique Backgrounded Membrane Imaging. ... HORIZON subvisible particle analysis system ...
Breaking Medicine Technology:
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand ... Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be ... Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection ...
Breaking Medicine News(10 mins):